Zacks Investment Research
25 May 2026, 14:56 UTC · 17w ago
Verdict
Headline leans bullish. We score BDSX +1.00 across three claims.
Score confirms the headline.
Leans bullish
From its wording — no explicit rating
+1.00strongly bullish
What the story claims
3 claims · scored −1 bearish … +1 bullish
Wall Street analysts have a consensus mean price target of $30.50 for Biodesix, Inc. (BDSX), representing a potential 104.3% upside from its last close of $14.93.
More positive than 92% of claims this week
Analysts are in agreement that Biodesix, Inc. will report earnings that exceed previous estimates.
Continue reading
5 related stories
More positive than 98% of ticker scores this week
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More positive than 76% of claims this week
Biodesix, Inc. shares have gained 40.3% over the past four weeks.
More positive than 49% of claims this week
Which stocks this story touches
More positive than 98% of ticker scores this week
The stock has gained 40.3% recently, and analysts suggest significant upside potential with a mean price target of $30.5 and positive earnings revisions.
More positive than 49% of ticker scores this week
Mentioned as having high page view growth, indicating increased investor interest.
More positive than 49% of ticker scores this week
Mentioned as having high page view growth, indicating increased investor interest.
More positive than 49% of ticker scores this week
Mentioned as having high page view growth, indicating increased investor interest.
More positive than 49% of ticker scores this week
Mentioned as having high page view growth, indicating increased investor interest.
More positive than 49% of ticker scores this week
Mentioned as having high page view growth, indicating increased investor interest.
More positive than 49% of ticker scores this week
Mentioned as having high page view growth, indicating increased investor interest.
More positive than 49% of ticker scores this week
Mentioned as having the highest page view growth, indicating increased investor interest.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
+90.4%
Price agrees with the score
$28.43 vs $14.93 close before publication (May 22) · not market-adjusted
BDSX chart →